Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Tindamax®* (Tinidazole Tablets 250mg & 500mg). Edenbridge will begin shipping its Tinidazole Tablets 250mg & 500mg products shortly. This is Edenbridge’s second FDA approval and one of several products filed by Edenbridge with the FDA. Tinidazole is a synthetic antiprotozoal and antibacterial agent for oral administration. For more information please contact the Company directly at info@dexcelpharmausa.com.
Tinidazole Tablets Approval
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.